News About: Pharm. Industry
Galvus gets nod for health insurance price
The health insurance price of Galvus (vildagliptin), a diabetes medicine produced by Novartis AG, has been finally agreed by Novartis Korea and the National Health Insurance Corporation.
The insurance price of Galv...
Pfizer Korea CEO named head of Pfizer business in Asia and Australia
Ahmet Goksun, President and CEO of Pfizer Korea, will be responsible for taking charge of overall business in Japan, Australia and New Zealand as of January 9, 2009.
The move comes after Pfizer Inc., the world's bi...
Green Cross aims for W615 billion sales
With its completion of new GMP plant in Osan, Chungchung Province last December, Green Gross Corporation has set an ambitious goal of 615 billion won in sales this year.
“We will produce a variety number of biodrug...
Roche Diagnostics Korea breaks 100 billion won in sales
Backed by successful introduction of innovative in-vitro diagnostics used in hospitals, such as CoaguChek XS system and cell analysis system, Roche Diagnostics Korea exceeded a 100 billion barrier this year and held i...
Wyeth Korea unionists end strike
The strike by Wyeth Korea unionists ended on January 12 after a pay deal agreement of 9.3 percent was reached between union leaders and management, creating a win-win spirit between the parties.
Under the agreement...
Ildong files patent for PDF inhibitors
lldong Pharm said it has recently filed a patent for novel peptide deformylase inhibitors and manufacturing methods thereof in U.S., Japan, Europe as well as Korea
Peptide deformylase (PDF), a metallohydrolase esse...
Shinpoong to build 33 billion won plant
Shinpoong Pham said it will invest about 33 billion won to build a plant producing cephalosporin antibiotics, according to a regulatory filing on January 12.
“To enter the U.S. market following the free trade agree...
Stable growth will give big boost to leading pharmaceutical shares
Boosted by flagship ethical products and more eased pricing rules on generic products by the government will give a green light to stocks of major pharmaceutical firms, such as Dong-A Pharm, Hanmi Pharm and Bukwang Ph...
Cialis to be available for once daily use
Lilly Korea says it will launch Cialis (tadalafil) 5 mg for once daily use, an oral medication taken once per day to treat erectile dysfunction (ED).
When Cialis for once daily use is taken daily, men can attempt ...
Kangdong launches S-amlodipine preparations
Kwandong Pharm has launched S-amlodipine besylate (3.74 mg) to expand its share in domestic hypertensive drug market.
S-amlodipine is a long-acting calcium channel blocker (dihydropyridine class) used as an antihyp...
